Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Adjunctive Fenfluramine in Adults with Lennox-Gastaut Syndrome: Effectiveness and Tolerability in Real-World Clinical Practice

AI Summary
  • Real-world evaluation of adjunctive fenfluramine in adults with Lennox-Gastaut syndrome assessing clinical effectiveness and tolerability.
  • Reports on seizure-frequency outcomes, responder rates and adverse events to inform benefit-risk assessment in routine clinical care.
  • Findings highlight implications for adult LGS management and the need for longer term and comparative studies to confirm effectiveness and safety.
Summarise with AI (MRCPsych/FRANZCP)

CNS Drugs. 2026 Jun 5. doi: 10.1007/s40263-026-01307-7. Online ahead of print.

NO ABSTRACT

PMID:42247076 | DOI:10.1007/s40263-026-01307-7

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review